Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-004406

Options or other derivatives

  • Chief Financial Officer acquired 150,071 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-01-19 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +103,894 103,894 D
2022-01-19 Grant or award : show line 2 in the form Restricted Stock Units +46,177 46,177 D
Loading xslF345X03/doc4.xml…